Navigation Links
MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCall's Microscope
Date:4/23/2013

LONDON, April 23, 2013 /PRNewswire/ --

Following the expiration of patents on several blockbuster drugs, big pharma companies have been looking to boost their product pipeline. While in-house research and development will be crucial to boost product pipeline, major pharma companies may also benefit by collaborating with emerging biotechnology companies that have developed or are developing potential blockbuster drugs. Biotechnology stocks ended mostly lower on Monday even as the broad market rose for a second successive trading session. Among the major movers in the biotechnology sector yesterday were MannKind Corporation (NASDAQ: MNKD), Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), Galena Biopharma Inc. (NASDAQ: GALE), and Novavax Inc. (NASDAQ: NVAX). StockCall has released full comprehensive research on MNKD, ARIA, ZIOP, GALE, and NVAX and these free technical analyses can be downloaded by signing up at

http://www.stockcall.com/technicalanalysis

Shares of MannKind Corporation edged lower on Monday. The stock traded between $3.86 and $4.07 before finishing the day 0.50% lower at $3.99 on volume of 2.70 million. MannKind's shares are currently trading more than 11.30% below their 52-week high. The stock has had an excellent run so far in 2013, gaining more than 72.70%. Shares of MNKD are currently trading well above their 50-day and 200-day moving averages which is a bullish signal. Free technical analysis on MNKD available by signing up at

http://www.StockCall.com/MNKD042313.pdf

Shares of Ariad Pharmaceuticals Inc. fell sharply yesterday even as the broad market posted gains. The stock closed 1.02% lower at $18.51 on above average volume of 3.59 million. Despite the losses seen on Monday, Ariad Pharma's shares are still up more than 1.40% in the last three trading sessions. Year-to-date, the stock is down nearly 3.50%. However, the biotech company's shares have seen a series of highs over the past few trading sessions, which suggests that market sentiment has turned bullish on the stock. Register today and access the free research on ARIA at

http://www.StockCall.com/ARIA042313.pdf

ZIOPHARM Oncology Inc.'s shares struggled in Monday's trading session, reversing some of the recent gains. The stock fell to an intra-day low of $1.67 before finishing the day 2.33% lower at $1.68 on volume of 760,400. Despite the losses yesterday, ZIOPHARM's shares gained more than 4.30% in the last three sessions. The stock's MACD has just crossed above the signal line, which suggests that market sentiment has once again turned bullish on ZIOP. Year-to-date, the company's shares are down nearly 60%. The free report on ZIOP can be downloaded by signing up now at

http://www.StockCall.com/ZIOP042313.pdf

Galena Biopharma Inc. shares fell sharply yesterday. The stock traded between $2.30 and $2.46 before finishing the day 3.33% lower at $2.32 on above average volume of 2.12 million. Despite the losses, Galena's shares are still trading close to their 52-week high of $2.60. The stock has had an excellent run so far in 2013, jumping more than 51%, compared to a gain of more than 9.50% for the S&P 500. Free report on GALE can be accessed by registering at

http://www.StockCall.com/GALE042313.pdf

Novavax Inc.'s shares edged higher in Monday's trading session, extending their gains from previous trading session. The stock closed 0.40% higher at $2.51 on volume of 919,000, taking its gains in the last three sessions to over 2.60%. Novavax's shares are currently trading well above their 50-day and 200-day moving averages. The stock's MACD, however, recently crossed below the signal line, which is a bearish signal. Register with StockCall and download the research on NVAX for free at

http://www.StockCall.com/NVAX042313.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com  


'/>"/>
SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
2. Enox Biopharma, Inc. Grants TTA LTD License To Wound Care Applications
3. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
4. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
5. Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCalls Microscope
6. Gundersen Lutheran Offers Heart Surgery with Less Pain, Faster Recovery
7. Smaller and more powerful electronics requires the understanding of quantum jamming physics
8. To Understand Chromosome Reshuffling, Look to the Genomes 3D Structure
9. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
10. Microbes may be engineered to help trap excess CO2 underground
11. Morning Sickness or NVP: National Survey of Nurse Practitioners Points to Underreporting of Common Condition in Pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... Michael Fitzmaurice recently became double board-certified in surgery and surgery of the hand ... Dr. Fitzmaurice is no stranger to going above and beyond in his pursuit ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Scientists at ... line options being tried for mesothelioma may be hampering the research that could lead ... research. Click here to read it now. , The team evaluated 98 ...
(Date:5/25/2016)... ... 25, 2016 , ... Lady had been battling arthritis since the age of ... left knee. Lady’s owner Hannah sought the help of Dr Jeff Christiansen of ... her cruciate ligament and help with the pain of Lady’s arthritis. Dr Christiansen suggested ...
(Date:5/24/2016)... ... May 24, 2016 , ... Cell therapies for a range ... by research at Worcester Polytechnic Institute (WPI) that yielded a newly patented method ... , The novel method, developed by WPI faculty members Raymond Page, PhD, professor ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):